Trials / Completed
CompletedNCT03637166
Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo)
Acute Exposure to Hypoxia in Precapillary Pulmonary Hypertension: Physiological and Clinical Effects at Rest and During Exercise
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to High Altitude ("Säntis"; 2500m above sea level) on pulmonary artery pressure and right heart function (echo)
Detailed description
Low altitude baseline measurements will be performed in Zurich (460m asl) including Echocardiography, Right heart catheterization, six-minute walk test (6MWT), pulmonary function test, clinical assessment and blood gas Analysis. Randomly assigned to the order of testing, the participants will be tested in Low Altitude (Zurich, 470m) and at High Altitude (2500m). Several times within the exposure, the pulmonary artery pressure (PAP) and the right heart function will be assessed by echo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Assessment at Low Altitude (470m above sea level) | Assessment at Low Altitude (in Zurich; 470m above sea level) in order to compare this data with High altitude exposure |
| OTHER | Exposure to High Altitude (2500m above sea level) | Exposure to High Altitude ("Säntis"; 2500m above sea level) for approximately 5 hours |
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2018-08-17
- Last updated
- 2020-01-07
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03637166. Inclusion in this directory is not an endorsement.